The Auckland based biotechnology company, Virionyx, is developing ground-breaking approached to infectious diseases, including a treatment for HIV.
They have successfully completed the US Federal Drug Agency's phase one clinical trials involving HIV positive volunteers, at Harvard Medical School Centre. There was early evidence of antiviral activity.
Virionyx now has the clearance for phase two trials to begin.
This is the first NZ developed biotheraputic to ever receive FDA clearance for clinical trials in the US.
Complete this month's questionnaire to qualify for extra Continuing Education credits. Click here For the answers to last month's quiz click here.
PHARMACY AWARDS
Click here for entry details for the 2003 Zuellig Pharma/Pharmacy Today Awards and to find out last year's winners. Also view and purchase photos of the 2002 Awards.
THIS ISSUE
For the leading stories in our latest issue of Pharmacy Today magazine visit our welcome page.
SUBSCRIPTIONS
To subscribe to Pharmacy Today, or to purchase The Beauty Manual or The Pharmacy Healthcare Handbook click here.
